Happy Holidays 2022
Verduci Editore sends warm holiday wishes and announces the summer closure from August 6th to August 21st.
Read More
Randomized Clinical Trial “Olfactory Dysfunction After COVID-19: Olfactory Rehabilitation Therapy vs. Treatment with Palmitoylethanolamide and Luteolin” – Preliminary Results
The study compares olfactory rehabilitation therapy with Palmitoylethanolamide and Luteolin treatment in post-COVID patients. Preliminary data show a significant recovery of olfactory function within two months.
Read More
Compendio di Neuroriabilitazione – 2nd Edition
The updated second edition of the “Compendio di Neuroriabilitazione” includes twelve new chapters, expanded sections on technology and cognitive disorders, and content tailored for professionals in the neurorehabilitation field.
Read More
Auguri Natale 2021
Season’s Greetings from Verduci Editore. During the holiday period, our offices will remain closed from December 24 to January 1.
Read More
Healthy Longevity International Conference
The full event video is available, including simultaneous Italian translation. A meeting dedicated to longevity research and to the presentation of the Italian edition of David Sinclair’s book “Lifespan”.
Read More
Zona della Risoluzione (Resolution Zone)
Introductory text presenting Barry Sears’ book on diet-induced silent inflammation, its link with major chronic diseases and the nutritional strategies proposed to prevent and resolve it, aiming to extend healthy lifespan.
Read More
Longevità (Lifespan – Italian edition)
Camillo Ricordi’s introduction to the Italian edition of David Sinclair’s Lifespan, presenting ageing as a potentially reversible disease and exploring the role of epigenetics, novel anti-ageing molecules and the ethical imperative of extending healthy lifespan.
Read More
Eculizumab treatment in patients with COVID-19: preliminary results from real-life ASL Napoli 2 Nord experience
Real-life case series of four severe ICU COVID-19 patients treated with eculizumab: all achieved clinical recovery, with marked CRP reduction and a mean disease duration of about 13 days, supporting the potential role of anti-complement C5 therapy in severe cases.
Read More
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
Preliminary (March 2020) review examining in vitro studies, clinical trials, expert reports and COVID-19 prevalence in malaria and non-malaria countries to explore the hypothesis that chloroquine and hydroxychloroquine might be effective in treating COVID-19.
Read More
COVID-19: L’inizio di una nuova era
A scientific and educational volume exploring the COVID-19 pandemic across all dimensions: clinical aspects, diagnosis, treatments, social impact, healthcare, risk factors and institutional responses, enriched with expert contributions.
Read More